「微元合成」获近3亿元融资，以甲醇为原料、开发大宗生物基产品｜早起看早期

Core Viewpoint - "Micro Yuan Synthesis" has recently secured nearly 300 million yuan in a new round of equity financing, with the funds primarily aimed at accelerating the research and development of methanol-based bio-manufacturing of bulk bio-based products [1][2]. Group 1: Company Developments - "Micro Yuan Synthesis" has successfully developed and industrialized several human and animal nutrition products, including allulose, lutein, and mannitol [1]. - The company has achieved significant commercial progress in the development of core products like allulose, becoming the first in China to receive administrative approval for allulose production through a biological fermentation process [1][2]. - A strategic partnership has been established with Cargill, focusing on the promotion and production collaboration of allulose and other sugar-reducing products [2]. Group 2: Industry Context - The global production of chemical products is approximately 2.3 billion tons annually, while bio-based products account for only 180 million tons, indicating a significant gap and potential for growth in bio-manufacturing [4]. - The development of non-grain bio-based products is essential, particularly using alternative carbon sources like straw and CO2, to address the challenges of raw material costs in bio-manufacturing [4]. - Methanol is identified as an ideal alternative carbon source, with China's coal-based methanol production capacity exceeding 10 million tons, representing 67% of the global total, and facing overcapacity issues [4].